Evidence map›Paper›PMID 42368379›Full record

ArticleCase reports in dermatological medicine2026

Leukemia Cutis Exhibiting the Koebner Phenomenon: A Rare Clinical Presentation of Acute Myeloid Leukemia.

Megan Hauptman, Joseph S Durgin, Ahmad Mattour, Shatha Farhan, Mio Nakamura, Michael Goldfarb

Abstract read
In one paragraph

Article in Case reports in dermatological medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Megan HauptmanDepartment of Dermatology, University of Michigan, Ann Arbor, Michigan, USA, umich.edu.ORCID https://orcid.org/0009-0009-2598-293X
Joseph S DurginDepartment of Dermatology, University of Michigan, Ann Arbor, Michigan, USA, umich.edu.ORCID https://orcid.org/0000-0002-1114-817X
Ahmad MattourDepartment of Hematology, Medical Oncology, Henry Ford, Detroit, Michigan, USA.
Shatha FarhanDepartment of Hematology, Medical Oncology, Henry Ford, Detroit, Michigan, USA.ORCID https://orcid.org/0000-0002-5723-7442
Mio NakamuraDepartment of Dermatology, University of Michigan, Ann Arbor, Michigan, USA, umich.edu.ORCID https://orcid.org/0000-0002-1367-742X
Michael GoldfarbDepartment of Dermatology, University of Michigan, Ann Arbor, Michigan, USA, umich.edu.ORCID https://orcid.org/0000-0002-5479-450X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leukemia cutis with predilection for sites of prior cutaneous trauma, often described as a Koebner-like phenomenon, is a rare but recognized occurrence. We present a unique case of an, otherwise, healthy male who developed leukemia cutis at a prior unrelated biopsy site, leading to a new diagnosis of acute myeloid leukemia (AML). Certain AML subtypes with extramedullary propensity, particularly M4 and M5, as seen in our patient, are associated with an increased risk of leukemia cutis. Unlike their medullary counterparts, extramedullary AML cells preferentially migrate to and persist in tissues outside the bone marrow, where the local microenvironment may promote immune escape. Although the localization of leukemia cutis to the biopsy site is consistent with a Koebner-like response, it remains uncertain whether subclinical leukemic cells were already present at the time of the initial excision; therefore, a definitive causal relationship between trauma and leukemic infiltration cannot be established. Additionally, the prior keratoacanthoma and its excision may have created a localized immunocompromised cutaneous district, or

Indexed as

acute myeloid leukemiaKoebner phenomenonleukemia cutis

Identifiers

PMID42368379
PMCPMC13308720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.